Tokyo, Japan

Hiroshi Nagasue

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Gotemba, JP (2017)
  • Shizuoka Prefecture, JP (2017)
  • Tokyo, JP (2018 - 2022)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovator Hiroshi Nagasue: Pioneering Pharmaceutical Crystals**

Introduction

Hiroshi Nagasue, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 7 patents, he focuses on the development of innovative pharmaceutical crystals, which are integral to enhancing drug formulations.

Latest Patents

Among his latest inventions, Nagasue has developed various types of crystals of tetrahydronaphthyl urea derivatives. These include type I, III, V, and VI crystals of 1-((1R,2R)-2-hydroxy-4,4-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)-3-(5-methyl-6-(2-methylpyrimidin-5-yl)-2-phenylpyridin-3-yl)urea. These crystals are particularly noteworthy as they serve as bulk pharmaceutical crystals with an excellent TrkA inhibitory effect, making them valuable in medicinal composition. Additionally, Nagasue provides innovative methods for producing these crystals, demonstrating his commitment to advancing pharmaceutical science.

Career Highlights

Hiroshi Nagasue has had an impactful career in leading pharmaceutical companies. He has collaborated with well-respected organizations such as Mochida Pharmaceutical Co., Ltd. and Merck Sharp & Dohme Corporation. His work within these companies has not only contributed to his own patent portfolio but has also advanced the overall field of drug development significantly.

Collaborations

Throughout his career, Nagasue has worked alongside notable colleagues such as Fumihiko Saitoh and Tomokazu Hirabayashi. These collaborations have fostered a rich exchange of ideas and expertise that have propelled their joint research efforts and led to innovative advancements in pharmaceutical applications.

Conclusion

Hiroshi Nagasue exemplifies the spirit of innovation in pharmaceuticals, particularly in the development of specialized medicinal crystals. With his extensive patent portfolio and collaborative efforts with esteemed companies and colleagues, he continues to be a driving force in the evolution of effective therapeutic solutions. His ongoing contributions promise to have a lasting impact on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…